Real-world Evidence Cancer trials are getting harder to complete, suggesting a role for more powerful RWE, AI solutions May 14, 2021Vol.47 No.19By Matthew Bin Han Ong
Trials & Tribulations It’s time to rethink clinical trials in a post-pandemic world May 14, 2021Vol.47 No.19By Dana Dornsife
In Brief Dana-Farber receives $50M gift from the Hale family for pancreatic cancer research May 14, 2021Vol.47 No.19
In Brief Christopher Lathan named chief clinical access and equity officer at Dana-Farber May 14, 2021Vol.47 No.19
In Brief MD Anderson, Broad Institute establish translational research platform focused on rare cancers May 14, 2021Vol.47 No.19
In Brief Jeffrey Miller receives $9M NCI grant to develop off-the-shelf NK cells May 14, 2021Vol.47 No.19
In Brief Leukemia & Lymphoma Society establishes IMPACT research grants to help underserved patients access clinical trials May 14, 2021Vol.47 No.19
Funding Opportunities Melanoma Research Foundation RFPs for 2021 Career Development Awards May 14, 2021Vol.47 No.19
